Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 8394593, 10 pages
https://doi.org/10.1155/2017/8394593
Research Article

Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status

1Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
2Department of Pathology, Klinikum Bayreuth, Bayreuth, Germany
3Private Practice for Gastroenterology, Alexanderstr. 2, 95444 Bayreuth, Germany
4Mikrogen GmbH, Neuried, Germany
5Department of Gastroenterology, Hepatology and Gastrointestinal Oncology, Bogenhausen Academic Teaching Hospital, Munich, Germany
6Institute for Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany
7Erasmus MC University Medical Center, Gastroenterology and Hepatology Rotterdam, Rotterdam, Netherlands
8Private Practice for Gastroenterology, Einsteinstraße 1, 81675 Munich, Germany
9DZIF German Centre for Infection Research, Munich, Germany

Correspondence should be addressed to Markus Gerhard; ed.mut@drahreg.sukram

Received 6 November 2016; Revised 12 February 2017; Accepted 15 March 2017; Published 30 May 2017

Academic Editor: Kristen M. Kahle

Copyright © 2017 Luca Formichella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bures, M. Kopácová, M. Skodová Fendrichová, and S. Rejchrt, “Epidemiologie Helicobacter pylori,” Vnitřní Lékařství, vol. 57, no. 12, pp. 993–999, 2011. View at Google Scholar
  2. J. G. Kusters, A. H. van Vliet, and E. J. Kuipers, “Pathogenesis of Helicobacter pylori infection,” Clinical Microbiology Reviews, vol. 19, no. 3, pp. 449–490, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Kuipers, A. M. Uyterlinde, A. S. Pena et al., “Long-term sequelae of Helicobacter pylori gastritis,” Lancet, vol. 345, no. 8964, pp. 1525–1528, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Marshall and J. R. Warren, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,” Lancet, vol. 1, no. 8390, pp. 1311–1315, 1984. View at Google Scholar
  5. C. S. Goodwin, J. A. Armstrong, and B. J. Marshall, “Campylobacter pyloridis, gastritis, and peptic ulceration,” Journal of Clinical Pathology, vol. 39, no. 4, pp. 353–365, 1986. View at Publisher · View at Google Scholar
  6. R. Pandey, V. Misra, S. P. Misra, M. Dwivedi, A. Kumar, and B. K. Tiwari, “Helicobacter pylori and gastric cancer,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 3, pp. 583–588, 2010. View at Google Scholar
  7. M. Witkowska and P. Smolewski, “Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma,” Mediators of Inflammation, vol. 2013, Article ID 523170, pp. 523170–523177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. I. Pereira and J. A. Medeiros, “Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas,” World Journal of Gastroenterology, vol. 20, no. 3, pp. 684–698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Correa, W. Haenszel, C. Cuello et al., “Gastric precancerous process in a high risk population: cross-sectional studies,” Cancer Research, vol. 50, no. 15, pp. 4731–4736, 1990. View at Google Scholar
  10. H. Enomoto, H. Watanabe, K. Nishikura, H. Umezawa, and H. Asakura, “Topographic distribution of Helicobacter pylori in the resected stomach,” European Journal of Gastroenterology & Hepatology, vol. 10, no. 6, pp. 473–478, 1998. View at Publisher · View at Google Scholar
  11. A. Jemal, F. Bray, M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” The New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. B. C. Wong, S. K. Lam, W. M. Wong et al., “Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial,” Jama, vol. 291, no. 2, pp. 187–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. F. Zambon, F. Navaglia, D. Basso, M. Rugge, and M. Plebani, “Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia,” Journal of Clinical Pathology, vol. 56, no. 4, pp. 287–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Rudi, A. Rudy, M. Maiwald, D. Kuck, A. Sieg, and W. Stremmel, “Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases,” The American Journal of Gastroenterology, vol. 94, no. 6, pp. 1525–1531, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Gao, M. N. Weck, A. Michel, M. Pawlita, and H. Brenner, “Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology,” Cancer Research, vol. 69, no. 7, pp. 2973–2980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Malfertheiner, F. Megraud, C. A. O’Morain et al., “Management of Helicobacter pylori infection–the Maastricht IV/Florence consensus report,” Gut, vol. 61, no. 5, pp. 646–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Ho and B. J. Marshall, “Accurate diagnosis of Helicobacter pylori. Serologic testing,” Gastroenterology Clinics of North America, vol. 29, no. 4, pp. 853–862, 2000. View at Google Scholar
  20. C. De Giacomo, L. Lisato, R. Negrini, G. Licardi, and G. Maggiore, “Serum immune response to Helicobacter pylori in children: epidemiologic and clinical applications,” The Journal of Pediatrics, vol. 119, no. 2, pp. 205–210, 1991. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kist, S. Strobel, T. Kirchner, and H. G. Dammann, “Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study,” FEMS Immunology and Medical Microbiology, vol. 24, no. 2, pp. 239–242, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. A. Veenendaal, A. S. Pena, J. L. Meijer et al., “Long term serological surveillance after treatment of Helicobacter pylori infection,” Gut, vol. 32, no. 11, pp. 1291–1294, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kato, N. Furuyama, K. Ozawa, K. Ohnuma, and K. Iinuma, “Long-term follow-up study of serum immunoglobulin G and immunoglobulin a antibodies after Helicobacter pylori eradication,” Pediatrics, vol. 104, no. 2, article e22, 1999. View at Publisher · View at Google Scholar
  24. N. Yunoki, K. Yokota, M. Mizuno et al., “Antibody to heat shock protein can be used for early serological monitoring of Helicobacter pylori eradication treatment,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 4, pp. 574–577, 2000. View at Google Scholar
  25. D. Wang, T. Chiu, and K. W. Chiu, “Clinical implication of immunoglobulin G levels in the management of patients with Helicobacter pylori infection,” Journal of American Board of Family Medicine, vol. 27, no. 5, pp. 682–689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Stolte and A. Meining, “The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment,” Canadian Journal of Gastroenterology, vol. 15, no. 9, pp. 591–598, 2001. View at Publisher · View at Google Scholar
  27. L. Formichella, L. Romberg, C. Bolz et al., “A novel immune-line assay based on recombinant virulence factors enables highly specific and sensitive serological diagnosis of H. pylori infection,” Clinical and Vaccine Immunology, vol. 20, no. 11, pp. 1703–1710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. Sobala, J. A. Pentith, A. T. Axon et al., “Screening dyspepsia by serology to Helicobacter pylori,” Lancet, vol. 338, no. 8759, pp. 94–96, 1991. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Valle, K. Seppälä, P. Sipponen, and T. Kosunen, “Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study,” Scandinavian Journal of Gastroenterology, vol. 26, no. 10, pp. 1057–1065, 1991. View at Google Scholar
  30. J. C. Atherton, P. Cao, R. M. Peek, M. K. Tummuru, M. J. Blaser, and T. L. Cover, “Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration,” The Journal of Biological Chemistry, vol. 270, no. 30, pp. 17771–17777, 1995. View at Google Scholar
  31. L. Gao, A. Michel, M. N. Weck, V. Arndt, M. Pawlita, and H. Brenner, “Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. Pylori proteins determined by novel multiplex serology,” Cancer Research, vol. 69, no. 15, pp. 6164–6170, 2009. View at Publisher · View at Google Scholar · View at Scopus